American Journal of Obstetrics & Gynecology
Volume 198, Issue 4 , Pages 382.e1-382.e8 , April 2008

Twin-to-twin transfusion syndrome: an antiangiogenic state?

Presented at the 28th Annual Meeting of the Society for Maternal–Fetal Medicine, Dallas, TX, Jan. 28-Feb. 2, 2008.

  • Juan Pedro Kusanovic, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI
    • ,
  • Roberto Romero, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI
    • Corresponding Author InformationReprints: Roberto Romero, MD, Perinatology Research Branch, NICHD, NIH, DHHS, Wayne State University/Hutzel Women’s Hospital, 3990 John R, Box 4, Detroit, MI 48201.
    • ,
  • Jimmy Espinoza, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI
    • ,
  • Jyh Kae Nien, MD

      Affiliations

    • Center for Perinatal Diagnosis and Research (CEDIP), Sotero del Rio Hospital, P. Universidad Catolica de Chile, Puente Alto, Chile
    • ,
  • Chong Jai Kim, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • Department of Pathology, Wayne State University, Detroit, MI
    • ,
  • Pooja Mittal, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI
    • ,
  • Sam Edwin, PhD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • ,
  • Offer Erez, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • ,
  • Francesca Gotsch, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • ,
  • Shali Mazaki-Tovi, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI
    • ,
  • Nandor G. Than, MD, PhD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • ,
  • Eleazar Soto, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI
    • ,
  • Natalia Camacho, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI
    • ,
  • Ricardo Gomez, MD

      Affiliations

    • Center for Perinatal Diagnosis and Research (CEDIP), Sotero del Rio Hospital, P. Universidad Catolica de Chile, Puente Alto, Chile
    • ,
  • Ruben Quintero, MD

      Affiliations

    • Department of Obstetrics and Gynecology, University of South Florida, Tampa, FL.
    • ,
  • Sonia S. Hassan, MD

      Affiliations

    • Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, and Detroit, MI
    • Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI

Received 2 December 2007 ,Revised 14 January 2008 ,Accepted 6 February 2008.

References 

  1. Bajoria R, Kingdom J. The case for routine determination of chorionicity and zygosity in multiple pregnancy. Prenat Diagn. 1997;17:1207–1225
  2. Dube J, Dodds L, Armson BA. Does chorionicity or zygosity predict adverse perinatal outcomes in twins?. Am J Obstet Gynecol. 2002;186:579–583
  3. Carroll SG, Tyfield L, Reeve L, Porter H, Soothill P, Kyle PM. Is zygosity or chorionicity the main determinant of fetal outcome in twin pregnancies?. Am J Obstet Gynecol. 2005;193:757–761
  4. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. The hidden mortality of monochorionic twin pregnancies. BJOG. 1997;104:1203–1207
  5. Gonzalez-Quintero VH, Luke B, O’Sullivan MJ, et al. Antenatal factors associated with significant birth weight discordancy in twin gestations. Am J Obstet Gynecol. 2003;189:813–817
  6. Leduc L, Takser L, Rinfret D. Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation. Am J Obstet Gynecol. 2005;193:1670–1675
  7. Sperling L, Kiil C, Larsen LU, et al. Naturally conceived twins with monochorionic placentation have the highest risk of fetal loss. Ultrasound Obstet Gynecol. 2006;28:644–652
  8. Bejar R, Vigliocco G, Gramajo H, et al. Antenatal origin of neurologic damage in newborn infants (II. Multiple gestations). Am J Obstet Gynecol. 1990;162:1230–1236
  9. Adegbite AL, Castille S, Ward S, Bajoria R. Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight. Am J Obstet Gynecol. 2004;190:156–163
  10. Fries MH, Goldstein RB, Kilpatrick SJ, Golbus MS, Callen PW, Filly RA. The role of velamentous cord insertion in the etiology of twin-twin transfusion syndrome. Obstet Gynecol. 1993;81:569–574
  11. Machin GA. Velamentous cord insertion in monochorionic twin gestation (An added risk factor). J Reprod Med. 1997;42:785–789
  12. Hanley ML, Ananth CV, Shen-Schwarz S, Smulian JC, Lai YL, Vintzileos AM. Placental cord insertion and birth weight discordancy in twin gestations. Obstet Gynecol. 2002;99:477–482
  13. Fick AL, Feldstein VA, Norton ME, Wassel FC, Caughey AB, Machin GA. Unequal placental sharing and birth weight discordance in monochorionic diamniotic twins. Am J Obstet Gynecol. 2006;195:178–183
  14. Patten RM, Mack LA, Harvey D, Cyr DR, Pretorius DH. Disparity of amniotic fluid volume and fetal size: problem of the stuck twin—US studies. Radiology. 1989;172:153–157
  15. Bajoria R, Wigglesworth J, Fisk NM. Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome. Am J Obstet Gynecol. 1995;172:856–863
  16. Bajoria R. Vascular anatomy of monochorionic placenta in relation to discordant growth and amniotic fluid volume. Hum Reprod. 1998;13:2933–2940
  17. Denbow ML, Cox P, Taylor M, Hammal DM, Fisk NM. Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome. Am J Obstet Gynecol. 2000;182:417–426
  18. Wee LY, Taylor M, Watkins N, Franke V, Parker K, Fisk NM. Characterisation of deep arterio-venous anastomoses within monochorionic placentae by vascular casting. Placenta. 2005;26:19–24
  19. Sebire NJ, Talbert D, Fisk NM. Twin-to-twin transfusion syndrome results from dynamic asymmetrical reduction in placental anastomoses: a hypothesis. Placenta. 2001;22:383–391
  20. Lutfi S, Allen VM, Fahey J, O’Connell CM, Vincer MJ. Twin-twin transfusion syndrome: a population-based study. Obstet Gynecol. 2004;104:1289–1297
  21. De Paepe ME, DeKoninck P, Friedman RM. Vascular distribution patterns in monochorionic twin placentas. Placenta. 2005;26:471–475
  22. Denbow M, Fogliani R, Kyle P, Letsky E, Nicolini U, Fisk N. Haematological indices at fetal blood sampling in monochorionic pregnancies complicated by feto-fetal transfusion syndrome. Prenat Diagn. 1998;18:941–946
  23. Mayhew TM. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta. 2002;23:742–750
  24. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis (I. Molecular regulation). Placenta. 2004;25:103–113
  25. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis (II. Changes during normal pregnancy). Placenta. 2004;25:114–126
  26. Lyall F, Greer IA, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. BJOG. 1997;104:223–228
  27. Kupferminc MJ, Daniel Y, Englender T, et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol. 1997;38:302–306
  28. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998;179:1539–1544
  29. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol. 2001;184:1267–1272
  30. Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405–1423
  31. Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003;88:5555–5563
  32. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658
  33. Koga K, Osuga Y, Yoshino O, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab. 2003;88:2348–2351
  34. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004;191:1240–1246
  35. Krauss T, Pauer HU, Augustin HG. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy. 2004;23:101–111
  36. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683
  37. Chaiworapongsa T, Romero R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia (Young Investigator Award). Am J Obstet Gynecol. 2004;190:1541–1547
  38. Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004;89:770–775
  39. Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005;57:1R–7R
  40. Chaiworapongsa T, Romero R, Kim YM, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med. 2005;17:3–18
  41. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594
  42. Bdolah Y, Karumanchi SA, Sachs BP. Recent advances in understanding of preeclampsia. Croat Med J. 2005;46:728–736
  43. Levine RJ, Thadhani R, Qian C, et al. Urinary placental growth factor and risk of preeclampsia. JAMA. 2005;293:77–85
  44. Rajakumar A, Michael HM, Rajakumar PA, et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 2005;26:563–573
  45. Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol. 2005;48:372–386
  46. Shibata E, Rajakumar A, Powers RW, et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005;90:4895–4903
  47. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;122:33–39
  48. Espinoza J, Nien JK, Kusanovic JP, et al. The combined use of uterine artery Doppler and maternal plasma placental growth factor concentrations identifies patients at risk for early onset and/or severe preeclampsia. Ultrasound Obstet Gynecol. 2006;28:387–388
  49. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642–649
  50. Robinson CJ, Johnson DD, Chang EY, Armstrong DM, Wang W. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol. 2006;195:255–259
  51. Aggarwal PK, Jain V, Sakhuja V, Karumanchi SA, Jha V. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int. 2006;69:621–624
  52. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992–1005
  53. Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol. 2006;194:1034–1041
  54. Crispi F, Dominguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006;195:201–207
  55. Malamitsi-Puchner A, Boutsikou T, Economou E, et al. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Mediators Inflamm. 2005;2005:293–297
  56. Boutsikou T, Malamitsi-Puchner A, Economou E, Boutsikou M, Puchner KP, Hassiakos D. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev. 2006;82:235–239
  57. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203:2165–2175
  58. Padavala S, Pope N, Baker P, Crocker I. An imbalance between vascular endothelial growth factor and its soluble receptor in placental villous explants of intrauterine growth-restricted pregnancies. J Soc Gynecol Investig. 2006;13:40–47
  59. Wallner W, Sengenberger R, Strick R, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007;112:51–57
  60. Signore C, Mills JL, Qian C, et al. Circulating angiogenic factors and placental abruption. Obstet Gynecol. 2006;108:338–344
  61. Espinoza J, Nien JK, Kusanovic JP, et al. A role of the anti-angiogenic factor sVEGFR-1 in the ’mirror syndrome’ (Ballantyne’s syndrome). Am J Obstet Gynecol. 2005;193:S134
  62. Espinoza J, Romero R, Nien JK, et al. A role of the anti-angiogenic factor sVEGFR-1 in the ’mirror syndrome’ (Ballantyne’s syndrome). J Matern Fetal Neonatal Med. 2006;19:607–613
  63. Rana S, Venkatesha S, DePaepe M, Chien EK, Paglia M, Karumanchi SA. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol. 2007;109:549–552
  64. Stepan H, Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med. 2006;354:1857–1858
  65. Espinoza J, Chaiworapongsa T, Romero R, et al. Unexplained fetal death: another anti-angiogenic state. J Matern Fetal Neonatal Med. 2007;20:495–507
  66. Kumazaki K, Nakayama M, Suehara N, Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol. 2002;33:1069–1077
  67. Scardo JA, Ellings JM, Newman RB. Prospective determination of chorionicity, amnionicity, and zygosity in twin gestations. Am J Obstet Gynecol. 1995;173:1376–1380
  68. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol. 1996;7:421–423
  69. Wood SL, St OR, Connors G, Elliot PD. Evaluation of the twin peak or lambda sign in determining chorionicity in multiple pregnancy. Obstet Gynecol. 1996;88:6–9
  70. Bracero LA, Byrne DW. Ultrasound determination of chorionicity and perinatal outcome in twin pregnancies using dividing membrane thickness. Gynecol Obstet Invest. 2003;55:50–57
  71. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22
  72. ACOG practice bulletin (Diagnosis and management of preeclampsia and eclampsia). No. 33, January 2002 Obstet Gynecol. 2002;99:159–167
  73. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group Am J Obstet Gynecol. 1997;177:1003–1010
  74. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87:163–168
  75. Gonzalez RP, Gomez RM, Castro RS, et al. [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. Rev Med Chil. 2004;132:1155–1165
  76. Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol. 1999;19:550–555
  77. Quintero RA, Quintero L, Pivatelli A, Bornick PW, Allen M, Johnson P. The donor-recipient (D-R) score: in vivo endoscopic evidence to support the hypothesis of a net transfer of blood from donor to recipient in twin-twin transfusion syndrome. Prenat Neonat Med. 2000;5:84–91
  78. Bermudez C, Becerra CH, Bornick PW, Allen MH, Arroyo J, Quintero RA. Placental types and twin-twin transfusion syndrome. Am J Obstet Gynecol. 2002;187:489–494
  79. Bermudez C, Becerra C, Bornick PW, Allen MH, Arroyo J, Quintero RA. Twin-twin transfusion syndrome with only superficial placental anastomoses: endoscopic and pathological evidence. J Matern Fetal Neonatal Med. 2002;12:138–140
  80. Lewi L, Van SD, Gratacos E, Witters I, Timmerman D, Deprest J. Monochorionic diamniotic twins: complications and management options. Curr Opin Obstet Gynecol. 2003;15:177–194
  81. Galea P, Jain V, Fisk NM. Insights into the pathophysiology of twin-twin transfusion syndrome. Prenat Diagn. 2005;25:777–785
  82. Harkness UF, Crombleholme TM. Twin-twin transfusion syndrome: where do we go from here?. Semin Perinatol. 2005;29:296–304
  83. Bajoria R, Ward S, Chatterjee R. Natriuretic peptides in the pathogenesis of cardiac dysfunction in the recipient fetus of twin-twin transfusion syndrome. Am J Obstet Gynecol. 2002;186:121–127
  84. Mahieu-Caputo D, Dommergues M, Delezoide AL, et al. Twin-to-twin transfusion syndrome (Role of the fetal renin-angiotensin system). Am J Pathol. 2000;156:629–636
  85. Sooranna SR, Ward S, Bajoria R. Discordant fetal leptin levels in monochorionic twins with chronic midtrimester twin-twin transfusion syndrome. Placenta. 2001;22:392–398
  86. Bajoria R, Gibson MJ, Ward S, Sooranna SR, Neilson JP, Westwood M. Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome. J Clin Endocrinol Metab. 2001;86:3150–3156
  87. Nevo O, Many A, Xu J, et al. Placental expression of sFlt-1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab. 2008;93:285–292
  88. Heyborne KD, Chism DM. Reversal of Ballantyne syndrome by selective second-trimester fetal termination (A case report). J Reprod Med. 2000;45:360–362
  89. Audibert F, Salomon LJ, Castaigne-Meary V, Alves K, Frydman R. Selective termination of a twin pregnancy as a treatment of severe pre-eclampsia. BJOG. 2003;110:68–69
  90. Heyborne KD, Porreco RP. Selective fetocide reverses preeclampsia in discordant twins. Am J Obstet Gynecol. 2004;191:477–480
  91. Pirhonen JP, Hartgill TW. Spontaneous reversal of mirror syndrome in a twin pregnancy after a single fetal death. Eur J Obstet Gynecol Reprod Biol. 2004;116:106–107
  92. Audibert F, Saloman LJ, Frydman R. Selective fetocide reverses preeclampsia in discordant twins. Am J Obstet Gynecol. 2005;193:894–895
  93. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic/soluble endoglin and soluble endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate. J Matern Fetal Neonatal Medicine. 2008;21:9–23

 This research was supported in part by the Intramural Research Program of the National Institute of Child Health and Human Development, NIH, DHHS.

 Cite this article as: Kusanovic JP, Romero R, Espinoza J, et al. Twin-to-twin transfusion syndrome: an antiangiogenic state? Am J Obstet Gynecol 2008;198:382.e1-382.e8.

PII: S0002-9378(08)00152-X

doi: 10.1016/j.ajog.2008.02.016

American Journal of Obstetrics & Gynecology
Volume 198, Issue 4 , Pages 382.e1-382.e8 , April 2008

Article Tools

* Image Usage & Resolution